How to Perform a Kirby-Bauer Disk Diffusion Test: Protocol and Quality Control

The Kirby-Bauer disk diffusion test, also known as the disk diffusion susceptibility test, is a standardized method for determining the susceptibility of bacterial isolates to antimicrobial agents. This method involves placing antibiotic-impregnated disks on an agar plate inoculated with a standardized bacterial suspension, incubating the plate, and measuring zones of inhibition around each disk to determine whether the bacterium is susceptible, intermediate, or resistant to each antibiotic. The Kirby-Bauer method is widely used in clinical, veterinary, and research microbiology laboratories for routine antimicrobial susceptibility testing due to its simplicity, reproducibility, and low cost. It is particularly useful for rapidly growing aerobic and facultative anaerobic bacteria, such as members of the Enterobacteriaceae, Staphylococcus spp., Enterococcus spp., and Pseudomonas aeruginosa. This protocol is designed for BSL-1 teaching laboratory settings using non-pathogenic or attenuated bacterial strains and should not be used for clinical diagnostic purposes without appropriate biosafety containment and regulatory approvals.

At a Glance

Scientific Principle

The Kirby-Bauer disk diffusion test is based on the diffusion of antibiotics from impregnated paper disks into solid agar medium. When an antibiotic disk is placed on an agar plate inoculated with a bacterial lawn, the antibiotic diffuses radially outward, establishing a concentration gradient. Bacterial growth occurs where the antibiotic concentration is below the minimum inhibitory concentration (MIC) for that organism, while a clear zone of inhibition appears where the concentration exceeds the MIC. The diameter of the inhibition zone is inversely related to the MIC: larger zones indicate greater susceptibility, while smaller or absent zones indicate resistance.

The test relies on several critical parameters that must be controlled for reproducible results. The agar depth must be consistent at 4 mm, as deeper agar allows more diffusion and produces larger zones. The inoculum density must be standardized to 0.5 McFarland (approximately 1.5 × 10⁸ CFU/mL for E. coli), as too heavy an inoculum produces smaller zones and too light an inoculum produces larger zones. The incubation temperature and time must be controlled, as temperature affects bacterial growth rate and antibiotic diffusion. The pH of the medium must be within 7.2-7.4, as pH affects antibiotic activity and bacterial growth.

The Kirby-Bauer method is a qualitative or semi-quantitative test that categorizes isolates as susceptible, intermediate, or resistant based on zone diameter breakpoints established by the Clinical and Laboratory Standards Institute (CLSI) or other national standards bodies. It is not a quantitative MIC method, but the zone diameter correlates with MIC values for most organism-antibiotic combinations. The method is standardized for rapidly growing aerobic bacteria and is not suitable for anaerobes, fastidious organisms, or slow-growing bacteria without specific modifications.

Materials and Instrumentation

Agar Medium

Mueller-Hinton agar (MHA) is the standard medium for Kirby-Bauer disk diffusion testing. This medium is selected because it supports the growth of most non-fastidious bacteria, has low sulfonamide, trimethoprim, and tetracycline antagonist content, and provides consistent diffusion characteristics. The agar should be prepared according to the manufacturer's instructions, autoclaved at 121°C for 15 minutes, and cooled to 45-50°C before pouring into sterile Petri dishes. The poured plates should have a uniform depth of 4 mm, which corresponds to approximately 25 mL of agar in a 100 mm diameter plate. Plates should be stored at 2-8°C in sealed plastic bags to prevent dehydration and used within 7 days of preparation.

For fastidious organisms, such as Streptococcus pneumoniae or Haemophilus influenzae, supplemented MHA is required. For S. pneumoniae, MHA supplemented with 5% defibrinated sheep blood is used. For H. influenzae, MHA supplemented with 1% hemoglobin and 1% IsoVitaleX is required. These modifications must be validated against CLSI standards for each organism-antibiotic combination.

Antibiotic Disks

Commercially prepared antibiotic disks are available from multiple manufacturers. Each disk contains a specific concentration of antibiotic, typically expressed in micrograms (μg) or units (U). The disks should be stored at -20°C or -70°C in sealed containers with desiccant to maintain potency. Working stocks can be stored at 2-8°C for up to one week. Disks should be allowed to equilibrate to room temperature for 1-2 hours before use to prevent condensation. Never use expired disks, as antibiotic degradation can produce false resistance results.

Inoculum Preparation

A sterile saline solution (0.85% NaCl) or Mueller-Hinton broth is used to prepare the bacterial suspension. The turbidity must be adjusted to match a 0.5 McFarland standard, which corresponds to approximately 1.5 × 10⁸ CFU/mL for E. coli. Commercial McFarland standards are available, or a barium sulfate standard can be prepared by mixing 0.5 mL of 1.175% barium chloride dihydrate with 99.5 mL of 1% sulfuric acid. The standard should be stored in the dark at room temperature and replaced monthly.

Equipment

• Sterile cotton swabs
• Forceps or disk dispenser
• Caliper or ruler for measuring zone diameters
• Incubator set to 35 ± 2°C
• Refrigerator for media and disk storage
• Autoclave or pressure cooker for media sterilization (see evidence [4])
• Biosafety cabinet for handling clinical isolates

Quality Control

Quality control is essential for the Kirby-Bauer disk diffusion test to ensure accurate and reproducible results. Control strains with known susceptibility patterns must be tested with each batch of media and each new lot of antibiotic disks. The recommended quality control strains include:

• Escherichia coli ATCC 25922: Used for quality control of antibiotics active against Enterobacteriaceae
• Staphylococcus aureus ATCC 25923: Used for quality control of antibiotics active against staphylococci
• Pseudomonas aeruginosa ATCC 27853: Used for quality control of antibiotics active against non-fermenters
• Enterococcus faecalis ATCC 29212: Used for quality control of antibiotics active against enterococci

The zone diameters for each control strain-antibiotic combination must fall within CLSI-established acceptable ranges. If any zone diameter falls outside the acceptable range, the test results are invalid, and corrective action must be taken. Common causes of out-of-range results include:

• Incorrect medium pH or depth
• Contaminated or degraded antibiotic disks
• Incorrect inoculum density
• Incorrect incubation temperature or time
• Contaminated control strains

Control strains should be subcultured weekly and stored on appropriate agar slants or in cryopreservation media. Fresh subcultures (18-24 hours old) should be used for each test. The purity of control strains should be verified by streaking on appropriate agar plates and examining colony morphology.

Conceptual Workflow

Step 1: Prepare the Inoculum

Select 3-5 well-isolated colonies of the test organism from an 18-24 hour culture on non-selective agar. Transfer the colonies to 2-3 mL of sterile saline or Mueller-Hinton broth using a sterile loop or swab. Vortex or mix thoroughly to create a uniform suspension. Adjust the turbidity to match the 0.5 McFarland standard by adding more organism or more diluent as needed. The suspension should be used within 15 minutes of preparation to maintain viability.

Step 2: Inoculate the Agar Plate

Dip a sterile cotton swab into the standardized bacterial suspension. Rotate the swab against the side of the tube above the liquid level to remove excess inoculum. Streak the swab evenly across the entire surface of the Mueller-Hinton agar plate in three directions (horizontal, vertical, and diagonal) to ensure confluent growth. Rotate the plate approximately 60 degrees between each streaking direction. Allow the plate to dry for 3-5 minutes with the lid slightly ajar to absorb excess moisture. Do not exceed 15 minutes of drying, as this can affect zone sizes.

Step 3: Apply Antibiotic Disks

Using sterile forceps or a disk dispenser, place the antibiotic disks onto the inoculated agar surface. Press each disk gently to ensure complete contact with the agar. Disks should be placed at least 24 mm apart (center to center) to prevent overlapping inhibition zones. For a standard 100 mm plate, no more than 6 disks should be placed. For a 150 mm plate, up to 12 disks can be placed. The disks should be placed within 15 minutes of inoculation to prevent drying of the agar surface.

Step 4: Incubate the Plate

Invert the plate and incubate at 35 ± 2°C for 16-18 hours in an aerobic incubator. Do not stack plates more than 3 high to ensure uniform temperature distribution. The incubation time should not exceed 24 hours, as extended incubation can cause antibiotic degradation and false resistance results. For fastidious organisms, incubation in 5% CO₂ may be required, but this can affect zone sizes for some antibiotics and must be validated.

Step 5: Measure Zone Diameters

After incubation, examine the plate for confluent bacterial growth. The lawn should be evenly distributed with no gaps or heavy patches. Measure the diameter of each inhibition zone to the nearest millimeter using a caliper, ruler, or automated zone reader. Hold the ruler across the center of the disk and measure the widest diameter of the zone of complete inhibition. For antibiotics that produce a haze of growth (e.g., sulfonamides, trimethoprim), measure the zone at the point of 80% inhibition. For swarming organisms (e.g., Proteus spp.), measure the zone at the edge of the swarming growth.

Step 6: Interpret Results

Compare the measured zone diameters to CLSI breakpoints for the specific organism-antibiotic combination. Record each result as susceptible (S), intermediate (I), or resistant (R). The intermediate category indicates that the isolate may be susceptible at higher antibiotic doses or at body sites where the antibiotic concentrates. Some antibiotics have different breakpoints for different organisms, so always consult the current CLSI M100 tables or equivalent national standards.

Quality Checks

Pre-Test Quality Checks

• Verify that Mueller-Hinton agar plates are within expiration date and free of contamination
• Check that antibiotic disks are within expiration date and stored properly
• Confirm that the 0.5 McFarland standard is within expiration date and properly mixed
• Verify that the incubator temperature is within 35 ± 2°C
• Ensure that control strains are pure and within subculture limits

During-Test Quality Checks

• Verify that the inoculum suspension is properly mixed and turbid
• Confirm that the agar surface is evenly inoculated with no gaps
• Check that disks are firmly in contact with the agar surface
• Ensure that disks are properly spaced to prevent zone overlap
• Record the time of inoculation and incubation start

Post-Test Quality Checks

• Verify that control strain zone diameters fall within acceptable ranges
• Check that the test organism lawn is confluent and evenly distributed
• Confirm that zone diameters are measured accurately to the nearest millimeter
• Ensure that results are recorded correctly and interpreted using current breakpoints
• Document any deviations from the standard protocol

Result Interpretation

The interpretation of Kirby-Bauer disk diffusion results requires comparison of measured zone diameters to CLSI breakpoints. These breakpoints are organism-specific and antibiotic-specific, and they are updated annually. The breakpoints categorize isolates into three groups:

• Susceptible (S): The isolate is inhibited by the usually achievable concentrations of the antibiotic when the recommended dosage is used for the site of infection. The zone diameter is equal to or greater than the susceptible breakpoint.

• Intermediate (I): The isolate is inhibited by the antibiotic at concentrations achievable when higher than normal dosages are used or when the antibiotic is concentrated at the site of infection. The zone diameter falls between the susceptible and resistant breakpoints.

• Resistant (R): The isolate is not inhibited by the usually achievable concentrations of the antibiotic with normal dosage schedules. The zone diameter is equal to or less than the resistant breakpoint.

For example, for E. coli tested against ciprofloxacin (5 μg disk), the CLSI breakpoints are:

• Susceptible: ≥ 21 mm
• Intermediate: 16-20 mm
• Resistant: ≤ 15 mm

These breakpoints are based on pharmacokinetic and pharmacodynamic data, clinical outcomes, and microbiological data. They are specific to the organism, antibiotic, and testing method. Always consult the most current CLSI M100 tables or equivalent national standards for the correct breakpoints.

Troubleshooting

Limitations

The Kirby-Bauer disk diffusion test has several important limitations that must be considered when interpreting results:

1. Qualitative nature: The test provides categorical results (S, I, R) rather than quantitative MIC values. This limits its utility for determining exact antibiotic concentrations needed for treatment.

2. Organism specificity: The method is standardized only for rapidly growing aerobic and facultative anaerobic bacteria. It is not suitable for anaerobes, mycobacteria, or fastidious organisms without specific modifications.

3. Antibiotic limitations: Some antibiotics diffuse poorly in agar (e.g., vancomycin, daptomycin) and may produce unreliable results. For these antibiotics, MIC methods are preferred.

4. Medium effects: The presence of blood, serum, or other supplements in the medium can affect antibiotic diffusion and bacterial growth. Supplemented media must be validated for each organism-antibiotic combination.

5. Incubation conditions: The standard aerobic incubation at 35°C is not suitable for organisms that require CO₂ or lower temperatures. Modified conditions must be validated.

6. Time requirement: The 16-18 hour incubation time is longer than some rapid methods, delaying results for clinical decision-making.

7. Subjective measurement: Manual measurement of zone diameters can introduce variability between operators. Automated zone readers can reduce this variability.

8. Breakpoint updates: CLSI breakpoints are updated annually, and laboratories must ensure they are using the most current tables. Using outdated breakpoints can lead to misclassification.

9. Heteroresistance: Some bacterial populations contain resistant subpopulations that may not be detected by disk diffusion, leading to false susceptibility results.

10. Biofilm effects: The test measures planktonic bacterial susceptibility and does not account for biofilm-associated resistance, which is relevant for device-related infections.

Documentation

Proper documentation is essential for reproducibility and quality assurance in the Kirby-Bauer disk diffusion test. The following information should be recorded for each test:

• Test date and time
• Organism identification and source
• Inoculum preparation method and McFarland standard used
• Medium type, lot number, and expiration date
• Antibiotic disks used (antibiotic name, disk concentration, lot number, expiration date)
• Incubation conditions (temperature, time, atmosphere)
• Control strain used and zone diameters obtained
• Test organism zone diameters for each antibiotic
• Interpretation (S, I, R) for each antibiotic
• Any deviations from the standard protocol
• Operator name and signature

Documentation should be maintained in a laboratory notebook or electronic laboratory information system. Quality control records should be reviewed regularly to identify trends or systematic errors. Out-of-range results should be documented with corrective actions taken.

Biosafety Considerations

The Kirby-Bauer disk diffusion test is typically performed with bacterial isolates that may be pathogenic. Appropriate biosafety precautions must be followed based on the risk group of the organism being tested. For BSL-1 organisms (non-pathogenic strains used in teaching laboratories), standard microbiological practices are sufficient, including hand washing, no eating or drinking in the laboratory, and proper waste disposal.

For BSL-2 organisms (clinical isolates or known pathogens), additional precautions are required, including:

• Work in a Class II biosafety cabinet
• Wear appropriate personal protective equipment (lab coat, gloves, eye protection)
• Decontaminate all waste before disposal
• Use sharps containers for broken glass and contaminated needles
• Follow institutional biosafety committee guidelines

The CDC and NIH Biosafety in Microbiological and Biomedical Laboratories (BMBL) provides comprehensive guidance for risk assessment and containment [6]. For research involving recombinant or synthetic nucleic acid molecules, the NIH Guidelines must be followed [7]. All laboratory personnel should receive appropriate training in biosafety and aseptic technique before performing the Kirby-Bauer test.

Frequently Asked Questions

Q1: Can I use the Kirby-Bauer method for anaerobic bacteria? No, the standard Kirby-Bauer method is not validated for anaerobic bacteria. Anaerobes require specialized testing conditions, including anaerobic incubation, supplemented media, and different breakpoints. For anaerobes, the agar dilution method or broth microdilution method is recommended.

Q2: How long can I store prepared Mueller-Hinton agar plates? Prepared Mueller-Hinton agar plates can be stored at 2-8°C for up to 7 days when sealed in plastic bags to prevent dehydration. Plates should be allowed to warm to room temperature before use. Do not use plates that show signs of contamination, dehydration (cracked agar), or discoloration.

Q3: What should I do if my control strain zone diameters are out of range? If control strain zone diameters fall outside the acceptable CLSI ranges, the test results are invalid. First, check all test parameters: medium pH and depth, inoculum density, incubation temperature and time, disk storage and expiration. Repeat the test with fresh control strains and new disks. If the problem persists, contact the medium or disk manufacturer for assistance.

Q4: Can I use the Kirby-Bauer method for slow-growing bacteria like mycobacteria? No, the standard Kirby-Bauer method is not suitable for slow-growing bacteria such as mycobacteria. These organisms require specialized testing methods, such as the agar proportion method for Mycobacterium tuberculosis or broth-based methods for nontuberculous mycobacteria. The incubation time and medium requirements are different from the standard Kirby-Bauer protocol.

References and Further Reading

1. Detection of carbapenem resistance and its attributable genes in Acinetobacter baumannii isolated from cardiac patients at a referral cardiac hospital of Kathmandu. B K P, Khadka S, Shrestha UT, Banjara MR. (2026). URL: https://pubmed.ncbi.nlm.nih.gov/41507808/

2. Occurrence, molecular confirmation, and multidrug resistance of methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius in companion animals in Indonesia. Alhadz GG, Salasia SIO, Lestari FB, Yosyana ARP, Wasissa M, Setianingrum YR, Widayanti R. (2026). URL: https://pubmed.ncbi.nlm.nih.gov/41822594/

3. Isolation, Identification and Pathogenicity Analysis of Proteus mirabilis in Cynomolgus Monkey From Yunnan, China. Li H, Qian Z, Luo L, Chen X, Tian B, Chen Z, Wang H. (2026). URL: https://pubmed.ncbi.nlm.nih.gov/41954268/

4. Evaluation of a commercial pressure cooker for the preparation of agar media for a diagnostic microbiology laboratory. Rubin JE, Huby F, Madalagama RP, de Alwis S, Wyshynski M, Jinadasa R. (2025). URL: https://pubmed.ncbi.nlm.nih.gov/41248111/

5. Herd Health Program Participation Associated with Lower Vancomycin Resistance and Multidrug Resistance in Dairy Mastitis Pathogens: A Five-Year Surveillance Study in Saraburi, Thailand. Wataradee S, Suriyasathaporn W, Somsee M, Samngamnim S, Khuprathumsiri A, Ajariyakhajorn K, Boonserm T. (2026). URL: https://pubmed.ncbi.nlm.nih.gov/42187746/

6. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. CDC and NIH. U.S. Department of Health and Human Services (2020). URL: https://www.cdc.gov/labs/bmbl/index.html

7. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. National Institutes of Health. URL: https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules/

8. NCBI Bookshelf: Molecular Biology and Laboratory Methods. National Center for Biotechnology Information. URL: https://www.ncbi.nlm.nih.gov/books/

Related Articles

• How to Interpret a Kirby-Bauer Disk Diffusion Test: Zone Diameter Measurement and CLSI Breakpoints
• How to Calculate the Number of Bacteria Using the Kirby-Bauer Disk Diffusion Method
• How to Interpret Kirby-Bauer Disk Diffusion Results Using CLSI Breakpoints
• How to Design a Reproducible Disk Diffusion Susceptibility Test Protocol
• How to Interpret Zone Diameter Measurements in Disk Diffusion Susceptibility Testing
• How to Perform an Antibiotic Susceptibility Test Using the Etest Method